GTP 200

Drug Profile

GTP 200

Alternative Names: GTP-200

Latest Information Update: 22 Jan 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gastrotech Pharma
  • Class Appetite stimulants; Peptide hormones
  • Mechanism of Action Growth hormone releasing factor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cachexia

Most Recent Events

  • 13 Feb 2006 Phase-II clinical trials in Cachexia in Sweden (unspecified route)
  • 13 Dec 2005 Phase I/II clinical trials in Cachexia in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top